CTNNB1 and adrenal cortex carcinoma: Kamilaris et al. found that overexpression of IGF2, mutations in TP53, ZNRF3, CTNNB1, and 11p15, and abnormal alterations in WNT/β-catenin and p53 signaling pathways contributed to the development of ACC [17].